Skip to main content
Premium Trial:

Request an Annual Quote

Parse Biosciences Partners With Decode Science for Australia, New Zealand Distribution

NEW YORK – Parse Biosciences announced on Tuesday that it has partnered with Decode Science to distribute its single-cell RNA-seq solutions in Australia and New Zealand.

Under the terms of the deal, Decode will provide customer service, technical support, sales and marketing, distribution, and related logistical efforts for the Parse product line — specifically its whole transcriptome, cell fixation, and nuclei fixation kits.

Decode is a distributor of genomic and multiomic products with established relationships at key accounts in the Oceania region, Parse said in a statement.

"We see these markets contributing substantially to our success and found the perfect partner in Decode," said Alex Rosenberg, CEO and cofounder of Seattle-based Parse Biosciences.

Parse Biosciences introduced split-pool combinatorial barcoding to the market earlier this year. The technology is an intrinsically scalable single-cell RNA-seq that does not require a separate hardware purchase, the firm said.

The Parse Bioscience Whole Transcriptome Kit is a single-cell assay that enables the profiling of up to 48 samples and 100,000 cells or nuclei. The Cell Fixation Kit and Nuclei Fixation Kit enable researchers to fix and store suspensions for up to six months.

Parse Biosciences noted that it will also present new capabilities of its platform at this year's American Society of Human Genetics meeting.